Ohio State University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Ohio State University sits in the top decile of US sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count).

552 total trials 117 currently recruiting 319 completed early-phase tilt top decile by trial count

Ohio State University: 552 sponsored US clinical trials, 117 recruiting.

Ohio State University sponsors 552 registered US clinical trials on ClinicalTrials.gov, 117 of them currently recruiting, and 319 completed. 39 of these trials are in Phase 3-4 (later-stage) and 60 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Suicidal Ideation, with 8 trials.

Top-decile sponsor footprint

Ohio State University ranks in the top decile of sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 57/100

319 of 366 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

552 total, page 9 of 12

COMPLETED NA

Effectiveness of Virtual Reality Gaming Therapy Versus CI Therapy for Upper Extremity Rehabilitation

NCT02631850

COMPLETED

Effect of Glucose Load on Expression of Advanced Glycation End Products in Women Screened for Gestational Diabetes

NCT03029546

COMPLETED Phase 1

Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study

NCT02265874

TERMINATED NA

Aggressive Driving and Road Rage: A Driving Simulation Experiment.

NCT03430973

COMPLETED NA

Cognitive and Emotion Regulation Training in MS

NCT02717429

COMPLETED NA

Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption

NCT02918422

COMPLETED Phase 1

Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)

NCT02535832

COMPLETED NA

A Skills-based RCT for Physical Activity Using Peer Mentors

NCT02329262

COMPLETED NA

Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches

NCT02351544

COMPLETED

PA Behavior and HRQoL in Parkinson's Disease Patients Patients: Role of Social Cognitive Variables

NCT05575479

TERMINATED NA

Ventilation With High Oxygen Content and Postoperative Pneumocephalus

NCT02722928

COMPLETED NA

Perioperative Cognitive Protection - Cognitive Exercise and Cognitive Reserve (The Neurobics Trial)

NCT02230605

COMPLETED NA

Dietary Soy Isoflavones In Chronic Pancreatitis

NCT02577640

COMPLETED NA

Suicide Prevention Among Substance Abusing Homeless Youth

NCT02576834

COMPLETED NA

Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Milk

NCT02482675

COMPLETED NA

Training of Eccentric Lower Extremity Function After SCI

NCT02498548

COMPLETED

Eccentric Motor Control After SCI

NCT02821845

COMPLETED Phase 1

Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes

NCT02409810

COMPLETED

Obstructive Sleep Apnea and Metabolic Health

NCT02978937

TERMINATED

Instrumented Thoracic and Lumbar Arthrodesis Supplemented by the Implanet Jazz SystemTMd

NCT02411799

COMPLETED Phase 3

Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy

NCT02354352

COMPLETED NA

ICG Use in Angiography for Nasoseptal Flap Harvest

NCT02117310

COMPLETED NA

Evaluation of EBT With Young, Substance Abusing Homeless Mothers

NCT02577666

COMPLETED NA

Effects of Capros in Patients With Type-1 Diabetes

NCT02634216

COMPLETED NA

Cardioprotective Activities Of Whole Eggs On Vascular Endothelial Function In Prediabetic Adults

NCT02364570

COMPLETED

Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)

NCT02544074

TERMINATED Early Phase 1

Statin Use in Patients With Acute VTE

NCT02331095

COMPLETED

Nutritional Regulation of Wound Inflammation: Part III

NCT02332993

COMPLETED NA

Bifocal Lenses In Nearsighted Kids

NCT02255474

COMPLETED NA

Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic

NCT02244099

COMPLETED NA

Integrated Second Language Learning for Chronic Care

NCT02864160

COMPLETED NA

Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery

NCT02643615

COMPLETED NA

Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD

NCT02251743

COMPLETED NA

Investigation of a Novel Sleep Surface for Treatment of Positional Sleep Apnea

NCT02250417

COMPLETED Phase 1

Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1

NCT02251457

COMPLETED

Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)

NCT02232750

COMPLETED NA

Clinical Trial of a Rehabilitation Game - SuperBetter

NCT01398566

COMPLETED NA

Contact Lens Adaptation in Neophytes

NCT02148263

TERMINATED NA

The Impact of Zinc Supplementation on Innate Immunity and Patient Safety in Sepsis

NCT02130388

COMPLETED NA

Pilot Study Assessing Computerized Cognitive Behavioral Therapy for Depression

NCT01990053

COMPLETED

Effect of Aging on Bariatric Surgery-induced Changes in Metabolism and Cognition

NCT02088190

TERMINATED Early Phase 1

Belatacept for Renal Transplant Recipients With Delayed Graft Function

NCT02134288

COMPLETED NA

Healthy Oils for Women (HOW Study)

NCT02063165

COMPLETED NA

Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin

NCT02076347

TERMINATED NA

Magnetic Resonance Elastography of Cardiac Transplant Rejection

NCT02266914

COMPLETED

Postoperative Delirium in Hip Arthroplasty Patients

NCT02323984

COMPLETED NA

Comparing Everolimus and Sirolimus in Renal Transplant Recipients

NCT01976390

COMPLETED Phase 2

Acetaminophen and Social Processes

NCT02108990

COMPLETED

The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study

NCT01942564

COMPLETED NA

Improving Patient Safety Through Simulation Research

NCT02097498

← Previous Page 9 of 12 Next →

Phase Distribution

PhaseTrial count
Phase 1 35
Phase 2 25
Phase 3 5
Phase 4 34

What is open in the Ohio State University pipeline

117 recruiting of 552 indexed (21% open); 319 completed (58%).

Phase mix: 39 late (III/IV) vs 60 early (I/II) (early-phase heavy).

Top condition: Suicidal Ideation (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Ohio State University: open-pipeline peers nationwide

Peers matched on 552 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 5%10%15%20%25% Total trials Recruiting share Ohio State UniversityAmgenMerck Sharp & DohmeVirginia Commonwealth UniversityOregon Health and Science UniversityUniversity of LouisvilleMedical College of WisconsinNova Southeastern UniversityColorado State University
Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 552 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this Ohio State University page

552 registered trials is a research-attention snapshot, not an endorsement of Ohio State University or any single study.

  • 117 of Ohio State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Suicidal Ideation is the condition Ohio State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Suicidal Ideation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ohio State University pipeline card: 552 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.